Page 365 - Avian Virology: Current Research and Future Trends
P. 365

356  |  Lupiani et al.

          generate novel recombinant vaccine candidates. Although BAC   the pathogenesis of MDV and subsequent development of more
          clone technology has a number of advantages, like the stabil-  effective vaccines.
          ity of insert propagation over multiple generations and mirror
          endogenous gene expression far more accurately than previously
          established cloning systems, it also has some limitations, like the   Life cycle
          time-consuming and labour-intensive generation and screen-  MD infected chickens shed virus through dander, which remains
          ing of recombinant BAC constructs, the oversized BAC DNA   infectious for several months. Under commercial rearing condi-
          constructs which are more easily sheared and degraded during   tions, chickens are exposed soon after hatching by inhaling dander
          manipulation before transfection, and some random recombina-  shed by infected chickens (Fig. 12.5) (Calnek, 1986, 2001). The
          tion events that may occur during the mutagenesis process.  lung appears to be the first site of entry of MDV into the chick-
                                                                ens. The exact role of the lung in MD pathogenesis remains to be
          CRISPR-Cas9 system                                    explored but is generally accepted that lung phagocytes play a role
          In recent years, the CRISPR-Cas9 system has emerged as a fast   in transmitting the virus to lymphocytes (Gimeno, 2008). MDV
          and reliable genome editing method. The CRISPR-Cas9 system   then establishes primary cytolytic infection in lymphoid tissues
          is a bacterial adaptive immune response mechanism used to pro-  from 2–7 days post infection, peaking at day 4. Primary infection
          tect bacteria from virus infection. Three types of CRISPR systems   occurs in  B-lymphocytes,  which  leads  to  activation  of  T-cells.
          have been identified and the type II CRISPR-Cas9 system is the   Unlike resting T-cells, which are fairly refractory to infection,
          most widely used for genome modification. Type II CRISPR-  activated T-cells are susceptible to infection (Schat et al., 1991).
          Cas9 system includes RNA-guided Cas9 endonuclease, a single   In  the  lymphocytes  the  virus  remains  strictly  cell-associated.
          guide RNA (sgRNA) and the trans-activating crRNA (tracr-  After 6–7 days post infection, antigen expression in lymphoid
          RNA) (Tang et al., 2018). The success of CRISPR-Cas9 system in   organs is down regulated leading to a switch from cytolytic to
          eukaryotic cells genome editing provide a novel method for large   latent phase. Some of these latently infected T-cells eventually
          DNA virus genome modification. In a recent study, CRISPR-  become transformed, within 2 weeks post infection, leading to a
          Cas9 technology was used to generate HVT recombinants by   lymphoproliferative disease in chickens. The virus is then carried
          expressing the VP2 gene of infectious bursal disease virus (IBDV)   to the skin by latently infected or transformed lymphocytes by
          providing a more feasible and efficient method to introduce genes   day 10–14, where the feather follicular epithelial cells become
          into  the  HVT  genome  for  rapid  development  of  recombinant   infected. Fully infectious MDV is then shed trapped in the kerati-
          vaccines (Tang et al., 2018). A recent report demonstrated that   nized epithelial cells that are very stable (Calnek, 2001).
          CRISPR-Cas9 could be used to study MDV gene function by   It has recently been reported that B cells are dispensable for
          deleting Meq and pp38 from the MDV vaccine strain CVI988   MDV replication, spread and tumour formation by utilizing newly
          (Zhang et al., 2018). Henceforth, the CRISPR-Cas9 technology   generated knockout chickens that lack mature and peripheral B
          will speed up the process to study the function of all MDV genes   cells (Bertzbach et al., 2018). This study suggests that MDV could
                                                                                           +
          leading to better understanding of the molecular mechanism of   rapidly infect and replicate in CD4  and CD8  T-cells and further
                                                                                                   +


                                                 Days post infection (dpi)

                       0                          7                          14                         21

                   Inhalation of   Early        Latently               Fully productive     Shedding of
                   infectious      cytolytic    infected               infection in         infectious virus
                   dander          infection of   T cells              feather follicle     in dander
                                   B cells &                           epithelium (FFE)
                                   activated T
                                   cells                    Transient
                                                            paralysis (TP)               Paralysis of leg/wings,
                                                                                         cachexia, blindness
                                                                        Persistent       immuno-suppression
                                                                        neurologic
                   Respiratory      Apoptosis                           disease (PND)
                   tract & lung     of B and T
                   phagocytic       cells                               Transformation      Lymphomas in
                   cells                                                of T cells          various organs



          Figure 12.5  Schematic representation of MDV life cycle.
                      Figure 5
   360   361   362   363   364   365   366   367   368   369   370